201 related articles for article (PubMed ID: 20300976)
1. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
Zhu F; Zhang Z; Wu G; Li Z; Zhang R; Ren J; Nong L
Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
[TBL] [Abstract][Full Text] [Related]
2. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
Yang X; Zhang Y; Wang S; Shi W
Can J Physiol Pharmacol; 2010 Sep; 88(9):874-9. PubMed ID: 20921973
[TBL] [Abstract][Full Text] [Related]
3. The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells.
Yang X; Liu Y; Zong Z; Tian D
Biomed Pharmacother; 2010 Jan; 64(1):58-62. PubMed ID: 19879105
[TBL] [Abstract][Full Text] [Related]
4. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
[TBL] [Abstract][Full Text] [Related]
5. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration.
Zhang Z; Ren JH; Li ZY; Nong L; Wu G
Oncol Rep; 2012 May; 27(5):1561-6. PubMed ID: 22344855
[TBL] [Abstract][Full Text] [Related]
6. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Chen J; Li ZY; Zhang RG; Zhu F; Wu G
Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
[TBL] [Abstract][Full Text] [Related]
7. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
[TBL] [Abstract][Full Text] [Related]
9. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
[TBL] [Abstract][Full Text] [Related]
10. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
11. Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells.
Zhang X; Wu N
Drug Des Devel Ther; 2018; 12():373-381. PubMed ID: 29503530
[TBL] [Abstract][Full Text] [Related]
12. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.
Yin L; Morishige K; Takahashi T; Hashimoto K; Ogata S; Tsutsumi S; Takata K; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2007 May; 6(5):1517-25. PubMed ID: 17513600
[TBL] [Abstract][Full Text] [Related]
13. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
Ying H; Biroc SL; Li WW; Alicke B; Xuan JA; Pagila R; Ohashi Y; Okada T; Kamata Y; Dinter H
Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB.
Xie T; Luo G; Zhang Y; Wang X; Wang X; Wu M; Li G
Clin Exp Allergy; 2015 Dec; 45(12):1812-22. PubMed ID: 26245530
[TBL] [Abstract][Full Text] [Related]
15. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
[TBL] [Abstract][Full Text] [Related]
16. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells.
Guerra FS; Oliveira RG; Fraga CAM; Mermelstein CDS; Fernandes PD
Sci Rep; 2017 Oct; 7(1):13723. PubMed ID: 29057980
[TBL] [Abstract][Full Text] [Related]
17. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
18. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion.
Li H; Peng W; Jian W; Li Y; Li Q; Li W; Xu Y
Cardiovasc Diabetol; 2012 Jun; 11():65. PubMed ID: 22694757
[TBL] [Abstract][Full Text] [Related]
19. HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
Nakabayashi H; Shimizu K
Cancer Sci; 2011 Feb; 102(2):393-9. PubMed ID: 21166955
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.
Yokota T; Utsunomiya K; Taniguchi K; Gojo A; Kurata H; Tajima N
Jpn J Ophthalmol; 2007; 51(6):424-30. PubMed ID: 18158592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
